Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Follow-on Offering
Follow-on Offering
Common Stock
Follow-on Offering
Additional Paid-In Capital
At-the-Market Equity Offering
At-the-Market Equity Offering
Common Stock
At-the-Market Equity Offering
Additional Paid-In Capital
Private Placement Offering 1
Private Placement Offering 1
Common Stock
Private Placement Offering 1
Additional Paid-In Capital
Private Placement Offering 2
Private Placement Offering 2
Common Stock
Private Placement Offering 2
Additional Paid-In Capital
Private Placement Offering 3
Private Placement Offering 3
Common Stock
Private Placement Offering 3
Additional Paid-In Capital
Balance at Dec. 31, 2022 $ 8,507,793 $ 1,096 $ 52,729,942 $ (44,207,272) $ (15,973)                              
Balance, Shares at Dec. 31, 2022   10,955,904                                    
Issuance of restricted stock 164,070 $ 4 164,066                                  
Issuance of restricted stock, Shares   40,500                                    
Stock-based compensation expense 537,522   537,522                                  
Foreign currency translation adjustment (9,301)       (9,301)                              
Net loss (4,116,876)     (4,116,876)                                
Balance at Mar. 31, 2023 5,083,208 $ 1,100 53,431,530 (48,324,148) (25,274)                              
Balance, Shares at Mar. 31, 2023   10,996,404                                    
Balance at Dec. 31, 2022 8,507,793 $ 1,096 52,729,942 (44,207,272) (15,973)                              
Balance, Shares at Dec. 31, 2022   10,955,904                                    
Net loss (13,516,243)                                      
Balance at Sep. 30, 2023 2,747,712 $ 1,377 60,513,616 (57,723,515) (43,766)                              
Balance, Shares at Sep. 30, 2023   13,761,123                                    
Balance at Mar. 31, 2023 5,083,208 $ 1,100 53,431,530 (48,324,148) (25,274)                              
Balance, Shares at Mar. 31, 2023   10,996,404                                    
Issuance of restricted stock 324,260 $ 9 324,251                                  
Issuance of restricted stock, Shares   96,521                                    
Issuance of warrants to underwriter in connection with follow-on offering 241,109   241,109                                  
Issuance of common shares           $ 4,156,859 $ 256 $ 4,156,603                        
Issuance of common shares, Shares             2,555,500                          
Stock-based compensation expense 618,932   618,932                                  
Issuance of stock options to satisfy accrued bonus 974,224   974,224                                  
Foreign currency translation adjustment (634)       (634)                              
Net loss (4,523,624)     (4,523,624)                                
Balance at Jun. 30, 2023 6,874,334 $ 1,365 59,746,649 (52,847,772) (25,908)                              
Balance, Shares at Jun. 30, 2023   13,648,425                                    
Exercise of stock options 1,433 $ 1 1,432                                  
Exercise of stock options, shares   750                                    
Issuance of restricted stock 194,630 $ 11 194,619                                  
Issuance of restricted stock, Shares   111,948                                    
Stock-based compensation expense 570,916   570,916                                  
Foreign currency translation adjustment (17,858)       (17,858)                              
Net loss (4,875,743)     (4,875,743)                                
Balance at Sep. 30, 2023 2,747,712 $ 1,377 60,513,616 (57,723,515) (43,766)                              
Balance, Shares at Sep. 30, 2023   13,761,123                                    
Balance at Dec. 31, 2023 477,511 $ 1,699 64,472,249 (63,980,177) (16,260)                              
Balance, Shares at Dec. 31, 2023   16,986,254                                    
Issuance of restricted stock 11,500 $ 1 11,499                                  
Issuance of restricted stock, Shares   12,500                                    
Issuance of common shares                 $ 565,623 $ 51 $ 565,572 $ 590,411 $ 250 $ 590,161 $ 90,618 $ 58 $ 90,560      
Issuance of common shares, Shares                   507,754     2,496,318     578,643        
Stock-based compensation expense 349,965   349,965                                  
Issuance of warrants in connection                       $ 230,685   $ 230,685            
Foreign currency translation adjustment (13,786)       (13,786)                              
Net loss (8,067,455)     (8,067,455)                                
Balance at Mar. 31, 2024 (5,764,928) $ 2,059 66,310,691 (72,047,632) (30,046)                              
Balance, Shares at Mar. 31, 2024   20,581,469                                    
Balance at Dec. 31, 2023 $ 477,511 $ 1,699 64,472,249 (63,980,177) (16,260)                              
Balance, Shares at Dec. 31, 2023   16,986,254                                    
Exercise of stock options, shares 118,610                                      
Net loss $ (19,682,718)                                      
Balance at Sep. 30, 2024 1,618,591 $ 2,397 85,290,791 (83,662,895) (11,702)                              
Balance, Shares at Sep. 30, 2024   23,966,814                                    
Balance at Mar. 31, 2024 (5,764,928) $ 2,059 66,310,691 (72,047,632) (30,046)                              
Balance, Shares at Mar. 31, 2024   20,581,469                                    
Exercise of stock options 185,646 $ 10 185,636                                  
Exercise of stock options, shares   101,837                                    
Issuance of common shares                 6,801,664 $ 202 6,801,462             $ 162,077 $ 49 $ 162,028
Issuance of common shares, Shares                   2,015,122                 494,096  
Stock-based compensation expense 413,948   413,948                                  
Issuance of warrants in connection                                   $ 172,925   $ 172,925
Exercise of warrants, shares   545,309                                    
Exercise of warrants 3,191,675 $ 54 3,191,621                                  
Reclassification of liability classified warrants to equity 6,870,296   6,870,296                                  
Foreign currency translation adjustment 7,868       7,868                              
Net loss (8,879,276)     (8,879,276)                                
Balance at Jun. 30, 2024 3,161,895 $ 2,374 84,108,607 (80,926,908) (22,178)                              
Balance, Shares at Jun. 30, 2024   23,737,833                                    
Exercise of stock options 30,192 $ 2 30,190                                  
Exercise of stock options, shares   16,773                                    
Issuance of restricted stock 100,000 $ 3 99,997                                  
Issuance of restricted stock, Shares   34,602                                    
Issuance of common shares                 $ 596,627 $ 18 $ 596,609                  
Issuance of common shares, Shares                   177,606                    
Stock-based compensation expense 455,388   455,388                                  
Foreign currency translation adjustment 10,476       10,476                              
Net loss (2,735,987)     (2,735,987)                                
Balance at Sep. 30, 2024 $ 1,618,591 $ 2,397 $ 85,290,791 $ (83,662,895) $ (11,702)                              
Balance, Shares at Sep. 30, 2024   23,966,814